DaVita Inc. Stock (DVA) - Quote Nyse- MarketScreener (2024)

DAVITA INC.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

DVA

US23918K1088

Real-time Estimate Cboe BZX Other stock markets 02:15:04 2024-06-26 pm EDT			5-day change	1st Jan Change
142.1 ^USD	-0.55%		+1.28%	+35.58%

Jun. 06	Nuwellis Extends Pilot Program With Dialysis Services Provider DaVita	MT
May. 24	FMC, Fresenius and Davita rise after Ozempic news	DP

Financials (USD)

Sales 2024 *	12.68B	Sales 2025 *	13.21B	Capitalization	12.53B
Net income 2024 *	775M	Net income 2025 *	811M	EV / Sales 2024 *	1.8x
Net Debt 2024 *	10.33B	Net Debt 2025 *	10.49B	EV / Sales 2025 *	1.74x
P/E ratio 2024 *	16x	P/E ratio 2025 *	14.3x	Employees	70,000
Yield 2024 *	-	Yield 2025 *	-	Free-Float	53.55%

More Fundamentals * Assessed data

Chart DaVita Inc.

Duration

Period

Style

Latest news about DaVita Inc.

Nuwellis Extends Pilot Program With Dialysis Services Provider DaVita	Jun. 06	MT
FMC, Fresenius and Davita rise after Ozempic news	May. 24	DP
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating	May. 15	MT
Transcript : DaVita Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM	May. 14
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing	May. 14	MT
DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024	May. 13	CI
TD Cowen Adjusts Price Target on DaVita to $139 From $136	May. 07	MT
UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating	May. 03	MT
Deutsche Bank Adjusts Price Target on DaVita to $145 From $135	May. 03	MT
Barclays Adjusts Price Target on DaVita to $150 From $133	May. 03	MT
DaVita gains after upbeat quarterly profit prompts annual forecast raise	May. 02	RE
DaVita Q1 Adjusted Earnings, Revenue Rise; 2024 EPS Guidance Range Narrows; Shares Gain After Hours	May. 02	MT
Transcript : DaVita Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (DVA) DAVITA Reports Q1 EPS $2.38, vs. Street Est of $1.89	May. 02	MT
Earnings Flash (DVA) DAVITA Reports Q1 Revenue $3.07B, vs. Street Est of $3.02B	May. 02	MT

More news

Latest transcript on DaVita Inc.

DaVita Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM

May. 14

More transcripts

Analyst Recommendations on DaVita Inc.

Nuwellis Extends Pilot Program With Dialysis Services Provider DaVita	Jun. 06	MT
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating	May. 15	MT
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing	May. 14	MT
TD Cowen Adjusts Price Target on DaVita to $139 From $136	May. 07	MT
UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating	May. 03	MT

More recommendations

Press releases DaVita Inc.

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase	Jun. 06	AQ
DaVita : Agenda	Jun. 04	PU
DaVita Appoints New Chief Information Officer	May. 13	PR
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference	May. 09	PR
DaVita Honors 54 Nephrology Nurses with DAISY Awards	May. 09	PR

More press releases

News in other languages on DaVita Inc.

FMC, Fresenius und Davita ziehen an nach Ozempic-Nachricht	May. 24
FMC verkauft Dialysekliniken in Südamerika mit Verlust	Mar. 05
Überraschend gute Davita-Zahlen treiben FMC und Fresenius an	Feb. 14
Gute Vorgaben von Davita für FMC	Feb. 14
Davita vorbörslich sehr gefragt - FMC steigt mit	Nov. 08

More news

Quotes and Performance

1 day	-1.22%
1 week	+0.73%
Current month	-3.98%
1 month	-1.67%
3 months	+4.45%
6 months	+35.17%
Current year	+34.85%

More quotes

Highs and lows

1 week

136.50

145.32

1 month

136.50

147.93

Current year

103.40

147.93

1 year

71.51

147.93

3 years

65.28

147.93

5 years

50.68

147.93

10 years

43.40

147.93

More quotes

Managers and Directors - DaVita Inc.

Managers	Title	Age	Since
Javier Rodriguez CEO	Chief Executive Officer	53	97-12-31
Joel Ackerman DFI	Director of Finance/CFO	59	17-02-26
Jeffrey Giullian CTO	Chief Tech/Sci/R&D Officer	-	19-11-30

Members of the board	Title	Age	Since
Barbara Desoer BRD	Director/Board Member	71	15-10-07
Phyllis Yale BRD	Director/Board Member	66	16-07-10
Wendy Schoppert BRD	Director/Board Member	57	23-07-13

More insiders

ETFs positioned on DaVita Inc.

Name	Weight	AuM	1st Jan change	Investor Rating
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD	15.19%	208 M€	+15.63%	-
ASYMSHARES ASYMMETRIC 500 ETF - USD	1.89%	16 M€	-3.37%
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.93%	2 M€	+8.54%
FIRST TRUST EQUITY COMPASS RISK MANAGER ETF - USD	0.67%	8 M€	+5.48%	-

More ETFs positioned on DaVita Inc.

Quotes

Date	Price	Change	Volume
24-06-26	142	-0.65%	254 855
24-06-25	142.9	-0.67%	628,812
24-06-24	143.9	+1.77%	1,129,129
24-06-21	141.4	+0.81%	5,696,210
24-06-20	140.2	-1.39%	1,040,699

Delayed Quote Nyse, June 26, 2024 at 11:07 am EDT

More quotes

Company Profile

DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;- other (4.7%).

Sector

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

Related indices

More about the company

Income Statement Evolution

More financial data

Ratings for DaVita Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

142.9USD

Average target price

142.2USD

Spread / Average Target

-0.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

	1st Jan change	Capi.
DAVITA INC.	+34.85%	12.53B
HCA HEALTHCARE, INC.	+25.05%	89.17B
CVS HEALTH CORPORATION	-24.05%	75.87B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	27.41B
LABCORP HOLDINGS INC.	-10.30%	17.52B
	-0.04%	17.04B
QUEST DIAGNOSTICS INCORPORATED	-0.14%	15.36B
NATERA, INC.	+77.36%	13.67B
TENET HEALTHCARE CORPORATION	+78.23%	13.18B
PURE HEALTH HOLDING	-25.61%	12.83B

Stock Market
Equities
DVA Stock

Secure and Increase the Performance of your Investments with our Team of Experts at your Side Securing my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '12378');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });